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Summary 
The seroprevalence of Rift Valley fever was determined in cattle, 
sheep and goats in selected areas of northern and central Burkina 
Faso. A total of 520 serum samples were screened for anti-Rift Valley 
fever virus immunoglobulin G (IgG) antibodies using an inhibition 
enzyme-linked immunosorbent assay (ELISA). An average 
seroprevalence of 7.67% (range 5% to 20%) was found in ruminants 
in Seno and Soum provinces, and prevalences of 20% and 22.5% in 
cattle in Yatenga and Oubritenga provinces, respectively. The Rev. sci. tech. Off. int. Epiz., 33 (3) 2 
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location, species and age of the animals was found to influence the 
seroprevalence. All the ELISA IgG-positive samples were tested for 
IgM in a competitive ELISA and were found negative, thus ruling out 
recent infections. The IgG-positive samples, including weak positives, 
were further tested in a serum neutralisation test for neutralising 
antibodies and 54.5% of these samples tested positive. The results 
show that the virus is in circulation in central and northern regions of 
Burkina Faso, suggesting the need for improved surveillance and 
control systems to prevent future outbreaks and the consequent 
economic impact of the disease in Burkina Faso livestock. 
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Introduction 
Rift Valley fever (RVF) is a zoonotic disease caused by a Phlebovirus 
in the family Bunyaviridae and is a World Organisation for Animal 
Health (OIE) notifiable disease that mainly affects sheep, cattle, goats 
and camels, although wildlife ruminants can also be infected (1). The 
RVF virus (RVFV) was first isolated in 1931, close to Lake Naivasha 
in the Kenyan Rift Valley (2). It is, however, thought that the disease 
may have occurred earlier, as an outbreak fitting the description of 
RVF and associated with heavy mortality in sheep was reported in the 
Kenyan Rift Valley in 1913 (1, 3). In ruminants, the main symptoms 
are abortion and mortality in young animals, with abortion and 
mortality rates being highest in sheep and goats (4, 5). 
Outbreaks of RVF in livestock on the African continent have been 
described many times, but the first outbreaks among human and 
livestock populations outside the continent were reported in the 
Arabian Peninsula in 2000 (6, 7). In West Africa, several outbreaks 
associated with human deaths have been described in Mauritania and 
Senegal (8, 9). Humans are usually infected by contact with the blood Rev. sci. tech. Off. int. Epiz., 33 (3) 3 
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and body fluids of infected animals during handling and slaughtering 
or from contact with contaminated meat during the preparation of 
food, or from the bites of infected mosquitoes (1, 10). In humans, the 
main clinical symptoms of the disease are those of an acute febrile 
illness, leading in the majority of cases to a haemorrhagic fever (11). 
Rift Valley fever virus is transmitted by mosquitoes, usually of the 
genus Aedes, acting as vectors of the disease. Epizootics of the fever 
occur periodically after heavy rainfall and in flooded areas (6, 12), 
which allow the mosquito eggs to hatch. 
Burkina Faso’s economy is primarily based on agriculture and about 
80% of the population rely on it for their livelihoods. Animal 
production contributes significantly to economic growth and in 2010 
represented 18% of the national gross domestic product. Moreover, 
the livestock value chain plays a crucial role in fighting poverty by 
boosting incomes in rural areas. In 2009, the number of domestic 
ruminants in Burkina Faso was estimated at 28 million head, 
comprising 8 million cattle, 8 million sheep and 12 million goats 
(approximate numbers) (13). More than 80% of these domestic 
ruminants are raised in the extensive/pastoral production system, 
which experiences numerous and multifaceted constraints, including 
repeated droughts and a high prevalence of parasitic and infectious 
diseases that lead to low productivity and affect food security. 
Some earlier studies have demonstrated evidence of the circulation of 
the virus in Burkina Faso and highlighted the need for continuous 
disease surveillance as a tool for early detection and control (9, 14, 
15). The aim of the present study was to screen animals for antibodies 
to the virus in two high-risk areas of the country in order to justify the 
establishment of regular serological and molecular surveys in sentinel 
herds, together with clinical, virological and epidemiological follow-
up of cases of fever of unknown origin in both human and animal 
populations. Rev. sci. tech. Off. int. Epiz., 33 (3) 4 
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Materials and methods 
Study areas 
Areas in central and northern Burkina Faso were selected for the 
study, based on the distribution of dams, swamps and ponds, and on 
rainfall data collected between 2005 and 2007. The study areas were 
the provinces of Oubritenga (12°  61′ N,  1° 32′  W) and Ganzourgou 
(12° 34′ N,  0° 84′  W) in the central region, and the provinces of 
Yatenga (13° 60′ N, 2° 46′ W), Seno (14° 05′ N, 0° 20′ W) and Soum 
(14′ N, 1° 67′ W) in the northern regions (Fig. 1). 
Sampling and sera 
Blood samples for serology were collected from herds that grazed 
around the following water reservoirs: the hydroelectric dam of Ziga 
(Oubritenga); Mogtedo dam (Ganzourgou); Koumbri and Ouahigouya 
dams (Yatenga); the pond of Djibo (Soum); the pond of Dori and 
Yakouta dam (Seno). These areas were considered a major risk for 
vector-borne infectious diseases. 
Sampled animals were classified according to age: <1 year, 1 to 3 
years, 3 to 5 years, >5 years. Blood samples were randomly collected 
in dry vacutainer tubes, allowed to clot at room temperature for 24 h 
and thereafter stored at +4°C. Sera were separated and stored at –20°C 
until used for serological testing. Each sample was labelled according 
to animal species, sex, age, herd holder and location.  
Analyses 
An inhibition enzyme-linked immunosorbent assay (ELISA) 
(Biological Diagnostic Supplies Limited, United Kingdom, 
www.bdsl2000.com) was used to screen for anti-RVFV 
immunoglobulin G (IgG) antibodies in accordance with the procedure 
described by the manufacturer (16). 
All IgG-positive samples, including any weak positives, were further 
tested using an IgM competitive ELISA to identify possible recent 
infections.  Rev. sci. tech. Off. int. Epiz., 33 (3) 5 
No. 08052014-00030-EN    5/18 
The serum neutralisation test, which is the accepted gold standard for 
anti-RVFV antibody detection, was used to determine the virus-
neutralising ability of the antibodies (7). In this assay, a serum sample 
is serially diluted and incubated with a standard dose of virus. If there 
are enough antibodies in the serum the viruses are neutralised. In order 
to evaluate the neutralisation effect, Vero cells are added to the 
serum/virus mixture and if neutralisation has occurred (titre  1/20) 
the cells remain intact without any cytopathic effect. In comparison 
with ELISA, the test is a sensitive and specific technique; however, 
the disadvantages are that it is time consuming and requires cell 
culture (17). 
The logistical regression model in Software R.2.0.0 (Language and 
Environment, 2004) was used for an analysis of variance on the 
classification criteria. Differences were considered significant at 
probability thresholds of 5% or <1%. 
Results 
Table  I shows the species and origin of the 520 sera that were 
analysed. 
Detection of anti-RVFV IgG antibodies in an inhibition 
enzyme-linked immunosorbent assay 
All 520 serum samples were screened for anti-RVFV IgG antibodies 
in an inhibition ELISA. Taking the northern and central regions of 
Burkina Faso together, the overall seroprevalence was 7.69% 
(40/520): the prevalence in the northern region was 9.37% and, in the 
central region, 5% (Table II).  
In the northern region, the highest prevalences were 22.5% in cattle in 
Yatenga province, followed by 20% in sheep and 17.5% in goats in 
Soum province. The lowest prevalence in cattle was in Seno province 
(7.5%). These areas of the northern region had significantly higher 
(p  0.001) prevalences of anti-RVFV antibodies in small ruminants 
than in other locations. In the central region, Oubritenga province had Rev. sci. tech. Off. int. Epiz., 33 (3) 6 
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the second-highest RVFV seroprevalences: 15% in cattle and 10% in 
sheep (Table II).  
Serology results by region and by species 
In the Northern provinces, the highest RVF seroprevalence for cattle 
was recorded in Yatenga (22.5%) and the lowest in Seno (7.5%). For 
goats, the highest seroprevalence was found in Soum (17.5%) and the 
lowest in Seno (2.5%). For sheep, the highest seroprevalence was 
recorded in Soum (20%) and the lowest in Seno (5%). 
In the central region, seropositivity was found in cattle (15%) and 
sheep (10%) in Oubritenga; the overall seroprevalence for small 
ruminants in Ganzourgou province was 0%. 
In the northern region, the overall seroprevalences were 15%; 8.33% 
and 6.66% for cattle, sheep and goats, respectively; in the central 
region overall seroprevalences were 15%, 5% and 0% respectively 
(Table III).  
Taking the two regions together, the highest seroprevalence was found 
in cattle (15%), followed by sheep (7%) and goats (4%). Thus, the 
RVFV seroprevalence varied significantly between species (p  0.05).  
Serology results by age group 
Seroprevalence varied by age group (Table IV). The highest 
seroprevalences were found in animals 3 to 5 years old (8.60%) and in 
those >5 years old (8%). Animals <1 year old and between 1 and 
3  years old had significantly lower seroprevalences at 4.54% and 
6.4%, respectively (p  0.001).  
Detection of anti-RVFV IgM antibodies in competitive 
enzyme-linked immunosorbent assay 
The 40 samples that tested positive for anti-RVFV IgG antibodies 
were retested in a competitive ELISA for IgM antibodies and all were 
found negative. Rev. sci. tech. Off. int. Epiz., 33 (3) 7 
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Detection of neutralising anti-RVFV antibodies in the serum 
neutralisation test 
A total of 55 sera (40 testing positive for IgG by ELISA, 15 giving an 
inconclusive result) were tested in the neutralisation test. Of these, 30 
(54.5%) were found to be positive for specific anti-RVFV antibody. 
The breakdown by species was as follows: sheep 75%, goats 72.2% 
and cattle: 11.8% (Table V).  
Discussion 
The study has demonstrated serological evidence of RVFV circulation 
among domestic ruminant populations in both northern and central 
Burkina Faso. There remains a need, however, to isolate and 
characterise the circulating viruses. The relatively high overall 
seroprevalence of 7.69% (9.37% in the northern region, 8.33% in 
Oubritenga province in the central region) clearly indicates that RVF 
could be a major health concern, thus warranting thorough 
investigation in this country. Data recorded 30 years ago (14) support 
the present finding that RVFV is circulating among domestic ruminant 
populations, with significant epidemiological importance, in Burkina 
Faso (1). However, the overall recorded seroprevalences of anti-
RVFV antibodies of 15% in cattle, 7% in sheep and 4% in goats were 
lower than those reported earlier, which ranged between 12.3% and 
14.8% (14, 15).  
The serological results in this study are compatible with earlier works 
in Cameroon (18), Togo (4), Kenya (2, 19) and Senegal (8). However, 
in comparison with other studies in East, West and Central Africa, the 
prevalence of anti-RVFV antibodies in small ruminants was lower at 
5.5% than that reported in the Senegal River basin (19.3%) (8), Côte 
d’Ivoire (9.71%) (20), Mauritania (85%), Cameroon (12.2%) Togo 
(6.1%) (15) and Chad (10.7%) (21), although it was higher than in 
Benin (1.71%) (4). In cattle, the observed seroprevalence was lower 
than previously reported in Benin (20.8%) and the Senegal River 
basin (27.4%) but higher than in Cameroon (9.35%) (15) and 
Madagascar (25.8%) (22). Rev. sci. tech. Off. int. Epiz., 33 (3) 8 
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In this study, location had a significant influence on RVFV 
seroprevalence. The highest seroprevalence was found in the northern 
region of Burkina Faso, which is an arid area that often has extensive 
stagnant water in ponds and dams during the rainy season. These 
conditions enable the hatching of transovarially infected Aedes in 
flood water and initiate local transmission (10, 12, 23). Other studies 
have also reported a high seroprevalence in arid regions and low 
seroprevalence in tropical regions (3, 6, 9, 22), and this is consistent 
with findings indicating a relationship between the timing and location 
of RVF epidemics and climatic indicators (9, 24, 25). In the present 
study, sheep and goats in the northern region had a higher 
seroprevalence of anti-RVFV antibodies than ruminants in the central 
region (5%), although in cattle the prevalence was the same (15%) in 
both regions. In the northern region in Seno and Soum provinces, all 
the tested animal species were affected by the virus, whereas in 
Yatenga province, only cattle were affected. In central Burkina Faso, 
anti-RVFV antibodies were detected only in Oubritenga province, 
where there is a hydroelectricity dam. The seroprevalence variation 
between locations may be secondary to the variation attributed to 
multiple other factors, including environmental ones (2, 19). The 
transmission of RVFV is closely related to flooding events and can 
also be widespread during periods of excessive rainfall (10, 18, 19).  
The present study also showed that the seroprevalence of anti-RVFV 
antibodies differed not only between the northern and central regions 
of Burkina Faso but also differed from pond to pond within the same 
province. The dams in Yatenga province and the hydroelectric dam in 
Oubritenga province had the highest anti-RVFV antibody rates for 
cattle at 22.5% and 15%, respectively, whereas the pond in Soum 
province had the highest seroprevalence rates for small ruminants 
(sheep: 20%, goats: 17.5%). These findings corroborate previous 
findings in Senegal River basin (8). The impact of both natural and 
artificial water sources on human and animal health should be 
carefully investigated to identify risk factors and facilitate the 
prediction of RVF epidemics, because the risk of human epidemics 
appears to be associated with prevalences of 15% to 20% in animals 
(21). Rev. sci. tech. Off. int. Epiz., 33 (3) 9 
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Cultural differences can also influence RVF risk. In the northern areas 
of Burkina Faso, people are nomadic pastoralists who practise 
transhumance during the dry season, where the animals could be in 
contact with RFV (2, 9, 11). This may explain the seropositivity in the 
cattle of Yatenga province, where only cattle are involved in 
transhumance. In contrast, both small ruminants and cattle are moved 
for transhumance in Soum and Seno provinces. The differences 
between species within the locations studied could be explained by the 
difference in production systems, where cattle and sheep are grazed 
together and goats are chained in the central region. Further 
investigations are needed to assess the effect of transhumance on the 
risk of RVFV transmission. 
The anti-RVFV antibody prevalence varied according to the animal 
species. In both the northern and central regions, cattle appeared more 
affected than sheep and goats. These findings corroborate earlier 
studies reporting that the first amplification cycle of the virus was 
mainly observed in cattle and humans (26). However, previous 
surveys in Chad (21), Saudi Arabia (6), Somalia (23), Madagascar 
(27) and Côte d’Ivoire (28) have shown that small ruminants were 
more affected than cattle. 
Age group also has a significant effect on RVFV seroprevalence. In 
the present study, an increased seroprevalence was recorded in older 
animals, and similar findings have been reported in Kenya (2), Chad 
(21), Togo (4), Somalia (23) and Madagascar (27). The relatively high 
prevalence in animals under one year of age, in association with 
abortion and stillbirth, indicates that there was recent and significant 
RVF circulation in the relevant regions, though without virus 
isolation. The high seroprevalence in this young age group could also 
be due to the presence of maternally derived antibodies. This is critical 
information, because it shows that there could be considerable RVFV 
activity in the country without any clinical signs of the disease. This 
situation has been confirmed in numerous studies in many other 
African countries (1). In 1985 and 2006 there were reports of animals 
being infected with the virus without visible signs of the disease in the 
animals or in humans (6, 10). Thus, the disease could exist in a Rev. sci. tech. Off. int. Epiz., 33 (3) 10 
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subclinical form similar to that reported in 2006 in Kenya and 
Tanzania (19), and in Mauritania and Senegal in 1987 (15, 29). 
All the samples in this study that tested positive for anti-RVFV IgG 
antibodies were found to be negative for IgM antibodies, therefore 
information on acute RVFV infection could not be obtained. Although 
this aspect has been less well studied, there are suggestions that anti-
RVFV IgM antibody is lost in 50% of animals by 45 days after 
infection and is absent in 100% at the fourth month after infection (12, 
30). Another limitation in detecting active infections was that the 
serum samples were collected two months after the end of the rainy 
season. 
The results of the neutralisation test confirmed the presence of specific 
anti-RVFV antibodies (17), showing that the virus is in circulation in 
both central and northern regions of Burkina Faso, although without 
any outbreaks. These results demonstrate that RVFV can, without 
doubt, be added to the complex aetiology of domestic ruminant 
abortions in Burkina Faso livestock (4, 31), and also in other regions 
in which the disease is enzootic (21, 23, 27, 32).  
Virus isolation studies and entomological surveys are needed to better 
understand these high levels of seroprevalence. Despite the absence of 
officially reported outbreaks of RVF in Burkina Faso, with clinical 
signs in animals, the national veterinary authorities need to develop 
strategies for the prevention and control of RVF, which take into 
account changes in the distribution of this climate-change-associated 
transboundary disease, including potential disease outbreaks (33). 
Conclusion 
This study in Burkina Faso showed that RVFV was present in 
livestock populations in the northern and central regions of the 
country, although anti-RVFV IgM antibodies were not detected. The 
highest seroprevalence was found in the northern region around 
temporary ponds and dams. Although the public health importance is 
unknown, the economic and epidemiological significance of RVF in 
Burkina Faso is of interest. Sentinel herds could be used to evaluate Rev. sci. tech. Off. int. Epiz., 33 (3) 11 
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recent infections and better predict possible outbreaks. Veterinarians 
and public health professionals should work together to ensure early 
detection of RVF in both animals and humans, in line with the One 
Health approach. The disease appears to be one of the main climate- 
change-associated diseases, therefore the climate should be regularly 
monitored to prevent and detect the invasion of mosquito populations, 
particularly after heavy rainfalls and flooding, which influence the 
disease dynamic and its impact on animal and human health. 
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Table I 
Species and origin of the sera analysed 
Province 
Species 
Total 
Cattle Sheep  Goats 
Seno   40    40    40    120 
Soum   0    40    40    80 
Yatenga   40    40    40    120 
Oubritenga   40    40    40    120 
Ganzourgou   0    40    40    80 
Total   120    200    200    520 
Table II 
Distribution of the prevalence of immunoglobulin G antibodies 
against Rift Valley fever virus, by species and province 
Region Province  Species  No. of 
sera tested 
No. of 
positive sera 
Percentage 
positive 
Northern Seno  (a) Cattle  40  3    7.5   
Goats 40  1    2.5   
Sheep 40  2   5   
Soum (b) Goats  40  7    17.5   
Sheep 40  8   20   
Yatenga (c) Cattle  40  9   22.5   
Goats 40     0 
Sheep 40     0 
Central Oubritenga  (d) Cattle  40  6    15   
Goats 40     0 
Sheep 40  4   10   
Ganzourgou (e) Goats  40      0 
Sheep 40     0 
Total   520  40    7.69 
a)  Dori pond and Yakouta dam 
b) Djibo  pond 
c)  Koumbri dam and Ouahigouya hydroelectric dam 
d)  Ziga hydroelectric dam 
e) Mogtedo  damRev. sci. tech. Off. int. Epiz., 33 (3) 17 
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Table III 
Distribution of the prevalence of immunoglobulin G antibodies 
against Rift Valley fever virus, by species and region 
Region Species  No. of 
sera tested 
No. of 
positive sera 
Percentage 
positive 
Northern Cattle    80  12    15 
Goats   120  8    6.66 
Sheep   120  10   8.33 
Total   320  30  
Central Cattle    40  6    15 
Goats   80  0    0 
Sheep   80  4   5 
Total   200  10   
Table IV 
Global prevalence of immunoglobulin G antibodies against Rift 
Valley fever virus, by age group 
Animal age 
group 
(years) 
No. of  
sera tested 
No. of 
positive sera 
Percentage 
positive 
<1   44 2    4.54 
1 to 3    125  8    6.4 
3 to 5    186    16    8.60 
>5   175    14    8 
Total   520    0   7.69 
Table V 
Detection of neutralising antibodies in the serum neutralisation 
test  
Species  No. of 
sera tested 
No. of 
positive sera 
Percentage 
positive 
Cattle 17  2    11.8 
Goats 18    13    72.2 
Sheep 20  15    75 
Total 55    30   54.5 Rev. sci. tech. Off. int. Epiz., 2014, 33 (3), ... - ... 
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